Financials in USD. Standardized financial statements.
A compact view of how Biotage AB (publ) turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.06B | $1.86B | $1.57B | $1.23B | $1.09B | $1.10B | $910.90M | $748.15M | $667.91M | $610.53M |
| Revenue Growth? | +10.4% | +18.9% | +27.1% | +12.8% | -0.9% | +20.9% | +21.8% | +12.0% | +9.4% | 0.0% |
| Cost of Revenue? | $767.00M | $713.00M | $618.00M | $477.00M | $426.00M | $415.96M | $354.27M | $291.48M | $282.10M | $267.97M |
| Gross Profit? | $1.29B | $1.15B | $948.00M | $755.00M | $667.00M | $685.41M | $556.63M | $456.66M | $385.81M | $342.57M |
| Gross Margin? | +62.7% | +61.7% | +60.5% | +61.3% | +61.1% | +62.2% | +61.1% | +61.0% | +57.8% | +56.1% |
| Operating Expenses? | $906.00M | $835.00M | $621.00M | $484.00M | $460.00M | $477.29M | $384.15M | $323.03M | $286.70M | $267.78M |
| Operating Income? | $383.00M | $314.00M | $327.00M | $271.00M | $206.00M | $208.12M | $172.48M | $133.63M | $99.11M | $74.79M |
| EBITDA? | $530.00M | $465.00M | $454.00M | $347.00M | $300.00M | $289.22M | $217.44M | $170.49M | $136.26M | $117.14M |
| Income Before Tax | $328.00M | $303.00M | $348.00M | $269.00M | $222.00M | $211.99M | $176.29M | $136.26M | $92.40M | $76.19M |
| Income Tax Expense | $44.00M | $57.00M | $80.00M | $64.00M | $47.00M | $25.17M | $8.66M | -$2.49M | -$394,000 | $2.94M |
| Net Income? | $284.00M | $246.00M | $268.00M | $205.00M | $175.00M | $186.82M | $167.63M | $138.75M | $92.80M | $73.25M |
| EPS? | $3.55 | $3.34 | $4.06 | $3.13 | $2.68 | $2.87 | $2.59 | $2.14 | $1.43 | $1.13 |
| Diluted EPS? | $3.55 | $3.33 | $4.04 | $3.13 | $2.68 | $2.87 | $2.59 | $2.14 | $1.43 | $1.13 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality